[1]
H. Fitzgerald, H. Carroll, and Y. Ahmed, “Pathological Response and Toxicity of Neoadjuvant Immunotherapy in Advanced Melanoma”, Ir Med J, vol. 119, no. 5, p. 84, May 2026.